In one paragraphArticle in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Cunfei MaState Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Department of Pharmaceutical Engineering, Dalian University of Technology, Dalian, China.
Kun TangState Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Institute of Chemical Process Systems Engineering, School of Chemical Engineering, Dalian University of Technology, Dalian, China.
Jingnan ZhaoState Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Department of Pharmaceutical Engineering, Dalian University of Technology, Dalian, China.
Yufeng WuState Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Department of Pharmaceutical Engineering, Dalian University of Technology, Dalian, China.ORCID https://orcid.org/0000-0002-2404-0053 Jianing LiState Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Department of Pharmaceutical Engineering, Dalian University of Technology, Dalian, China.
Qilei LiuState Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Department of Pharmaceutical Engineering, Dalian University of Technology, Dalian, China.ORCID https://orcid.org/0000-0002-3879-1827 Qingwei MengState Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Department of Pharmaceutical Engineering, Dalian University of Technology, Dalian, China.ORCID https://orcid.org/0000-0002-1743-2518 Funding
Dalian Unisiversity of Technology DUT22LAB608National Natural Science Foundation of China U20A20143
6 · The paper itselfAbstract
Indexed as
C1‐symmetric salanenantioselective hydroxylationkey intermediates of indoxacarbβ‐keto esters
Identifiers
PMID42471306
PMCPMC13380636
What OpenQuestion holds
Textmetadata
Read underepoch 390